The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy

This study is to examine the significance of the number and ratio of positive nodes in post‐neoadjuvant therapy pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC).

[1]  Jeffrey E. Lee,et al.  Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer , 2015, Annals of Surgical Oncology.

[2]  D. Gouma,et al.  Question Sets and Answers , 2014, Surgery.

[3]  A. Lazar,et al.  Locoregional Disease Patterns in Well-Differentiated and Dedifferentiated Retroperitoneal Liposarcoma: Implications for the Extent of Resection? , 2014, Annals of Surgical Oncology.

[4]  M. Lesurtel,et al.  Extended Lymphadenectomy in Patients With Pancreatic Cancer Is Debatable , 2013, World Journal of Surgery.

[5]  D. Coniglio.  Collaborative practice models and team-based care in oncology. , 2013, Journal of oncology practice.

[6]  Jeffrey E. Lee,et al.  Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation , 2012, Cancer.

[7]  Jeffrey E. Lee,et al.  Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma , 2012, Cancer.

[8]  T. Takada,et al.  Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas , 2012, Journal of hepato-biliary-pancreatic sciences.

[9]  B. Haugk,et al.  Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  T. Therneau,et al.  Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[11]  Jeffrey E. Lee,et al.  Post‐therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation , 2012, Cancer.

[12]  A. Benson,et al.  The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. , 2011, International journal of radiation oncology, biology, physics.

[13]  M. Ferri,et al.  Role of the Lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis , 2011, Journal of surgical oncology.

[14]  C. Yeo,et al.  The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma , 2011, Journal of Gastrointestinal Surgery.

[15]  D. Semeraro,et al.  Lymph Node Ratio Versus Number of Affected Lymph Nodes as Predictors of Survival for Resected Pancreatic Adenocarcinoma , 2010, World Journal of Surgery.

[16]  T. Keck,et al.  The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer , 2009, Journal of Gastrointestinal Surgery.

[17]  Jeffrey E. Lee,et al.  Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Jeffrey E. Lee,et al.  Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Giuseppe Garcea,et al.  Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature. , 2008, JOP : Journal of the pancreas.

[20]  M. Choti,et al.  Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis , 2007, Annals of Surgical Oncology.

[21]  M. Gönen,et al.  Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer , 2007, Journal of Gastrointestinal Surgery.

[22]  M. Choti,et al.  Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. , 2007, Surgery.

[23]  M. Sierzega,et al.  The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head Cancer , 2006, Pancreas.

[24]  David D. Smith,et al.  Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database , 2006, Annals of Surgical Oncology.

[25]  C. Earle,et al.  Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients , 2003, Annals of surgery.

[26]  J. Forgensen.  Resected adenocarcinoma of the pancreas--616 patients: results, outcomes, and prognostic indicators. , 2001, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

[27]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.